Back to TEVA
STATE STREET CORP TEVA Position History
Teva Pharmaceutical Industries Limited • Healthcare
Quarters held
12
Latest value
$641.6M
Q2 2026
Peak value
$641.6M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $170.9M |
| Q1 2024 | $228.9M |
| Q2 2024 | $288M |
| Q3 2024 | $351.4M |
| Q4 2024 | $427.9M |
| Q1 2025 | $266.2M |
| Q2 2025 | $289.7M |
| Q3 2025 | $346.4M |
| Q4 2025 | $541.5M |
| Q1 2026 | $535.8M |
| Q2 2026 | $641.6M |
| Q2 2026 | $641.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $641.6M | 18.94M | — | — |
| Q2 2026 | $641.6M | 18.94M | — | — |
| Q1 2026 | $535.8M | 17.79M | — | — |
| Q4 2025 | $541.5M | 17.35M | — | — |
| Q3 2025 | $346.4M | 17.15M | — | — |
| Q2 2025 | $289.7M | 17.29M | — | — |
| Q1 2025 | $266.2M | 17.32M | — | — |
| Q4 2024 | $427.9M | 19.41M | — | — |
| Q3 2024 | $351.4M | 19.50M | — | — |
| Q2 2024 | $288M | 17.72M | — | — |
| Q1 2024 | $228.9M | 16.22M | — | — |
| Q4 2023 | $170.9M | 16.37M | — | — |